Revealing the Function of Red Algae Extract Formulated with Nanotechnology in Cancer Treatment

Yalio Denim^*
*Correspondence: Yalio Denim, Department of Urology, Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, MN 55455, USA, Email:

Keywords

Carrageenans • Phycobiliproteins • Nanoparticles

Introduction

Cancer remains one of the leading causes of mortality worldwide, driving the continuous search for effective treatments. Traditional therapies like chemotherapy and radiation have limitations, including non-specific targeting and severe side effects. Therefore, novel therapeutic strategies are essential. Marine organisms, particularly red algae, have emerged as a rich source of bioactive compounds with potential anticancer properties. Recent advancements in nanotechnology have further opened new avenues for enhancing the delivery and efficacy of these natural compounds [1].

Literature Review

Red algae (Rhodophyta) are known for their diverse range of bioactive compounds, including polysaccharides, phycobiliproteins, carotenoids, and polyphenols. Among these, sulfated polysaccharides like carrageenans have shown notable anticancer activities. These compounds exhibit various mechanisms of action, such as inducing apoptosis, inhibiting angiogenesis, and modulating immune responses. Carrageenans, sulfated polysaccharides extracted from red algae, have been widely studied for their biological activities. They exhibit anticancer effects by inducing apoptosis in cancer cells, inhibiting metastasis, and enhancing immune responses. Studies have demonstrated that carrageenans can inhibit the growth of various cancer cell lines, including breast, colon, and liver cancers. Phycobiliproteins, another significant group of compounds found in red algae, are known for their fluorescent properties and potential health benefits. These proteins have shown antioxidant and anti-inflammatory activities, which can indirectly contribute to their anticancer properties by reducing oxidative stress and inflammation, conditions often associated with cancer progression [2,3].

Nanotechnology involves manipulating matter on an atomic or molecular scale, typically less than 100 nanometers. In cancer treatment, nanotechnology has revolutionized drug delivery systems, enhancing the solubility, stability and bioavailability of therapeutic agents. Nanoparticles can be engineered to deliver drugs directly to cancer cells, minimizing damage to healthy tissues and reducing side effects. Several types of nanoparticles are utilized in cancer therapy, including: Lipid-based nanoparticles include liposomes and solid lipid nanoparticles, known for their biocompatibility and ability to encapsulate both hydrophilic and hydrophobic drugs. Polymeric nanoparticles made from biodegradable polymers, these nanoparticles provide controlled release of the encapsulated drugs. Gold and silver nanoparticles are used for their unique optical and electronic properties, facilitating targeted drug delivery and imaging [4].

Discussion

Integrating red algae extracts with nanotechnology aims to overcome the limitations of conventional therapies. The encapsulation of red algae-derived compounds in nanoparticles enhances their stability, bioavailability, and targeted delivery to cancer cells. Nanoparticles improve the solubility and stability of red algae extracts, ensuring a higher concentration of active compounds reaches the tumor site. Functionalizing nanoparticles with ligands such as antibodies or peptides allows for specific targeting of cancer cells, reducing off-target effects. Nanoparticles can be designed to release their payload in a controlled manner, providing sustained therapeutic levels of the active compounds [5].

Several studies have investigated the efficacy of red algae extracts formulated with nanotechnology in cancer treatment: In vitro studies have shown that nanoparticles encapsulating red algae extracts can effectively induce apoptosis and inhibit proliferation in various cancer cell lines. For instance, carrageenan-loaded nanoparticles have demonstrated significant cytotoxic effects against breast and colon cancer cells. Animal models have been used to study the bio distribution and therapeutic efficacy of red algae extract nanoparticles. These studies indicate improved tumor targeting and reduced systemic toxicity compared to conventional formulations. Nanoparticles enhance the therapeutic effects of red algae extracts by increasing their bioavailability and enabling targeted delivery. By targeting cancer cells specifically, nanoparticles minimize damage to healthy tissues and reduce side effects associated with conventional chemotherapy. Nanoparticles can be engineered to carry multiple drugs or imaging agents, offering a multifunctional platform for cancer diagnosis and treatment [6,7].

Conclusion

The future of red algae extract formulated with nanotechnology in cancer treatment looks promising. Optimizing nanoparticle design enhances the stability, targeting efficiency, and controlled release properties of nanoparticles. Combination therapies investigate the synergistic effects of red algae extracts with other anticancer agents or therapies. Clinical trials conducting more comprehensive clinical trials to establish the safety and efficacy of these formulations in humans. Red algae extracts, when formulated with nanotechnology, offer a novel and promising approach to cancer treatment. By enhancing the bioavailability and targeted delivery of bioactive compounds, nanotechnology significantly improves the therapeutic potential of red algae-derived compounds. Continued research and clinical validation are essential to fully realize the potential of this innovative therapy, potentially revolutionizing the future of cancer treatment.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Crosby, David, Sangeeta Bhatia, Kevin M. Brindle and Lisa M. Coussens, et al. "Early detection of cancer." Sci 375 (2022): eaay9040.

Google Scholar, Crossref, Indexed at

2. Deyab, Mohamed, Jelan Mofeed, Emad El-Bilawy and Fatma Ward. "Antiviral activity of five filamentous cyanobacteria against coxsackievirus B3 and rotavirus." Arch Microbiol 202 (2020): 213-223.

Google Scholar, Crossref, Indexed at

3. Girigoswami, Agnishwar and Koyeli Girigoswami. "Potential applications of nanoparticles in improving the outcome of lung cancer treatment." Genes 14 (2023): 1370.

Google Scholar, Crossref, Indexed at

4. Ps, Sharon Sofini, Arina Guha, Balasubramanian Deepika and Saranya Udayakumar, et al. "Nanocargos designed with synthetic and natural polymers for ovarian cancer management." Naunyn-Schmiedeberg's Arch Pharmacol 396 (2023): 3407-3415.

Google Scholar, Crossref, Indexed at

5. Kenchegowda, Madhuchandra, Mohamed Rahamathulla, Umme Hani and Mohammed Y. Begum, et al. "Smart nanocarriers as an emerging platform for cancer therapy: A review." Mol 27 (2021): 146.

Google Scholar, Crossref, Indexed at

6. Nsairat, Hamdi, Dima Khater, Usama Sayed and Fadwa Odeh, et al. "Liposomes: Structure, composition, types and clinical applications." Heliyon 8 (2022).

Google Scholar, Crossref, Indexed at

7. Sanei-Dehkordi, Alireza, Abdolmajid Ghasemian, Elham Zarenezhad and Hajar Qasemi, et al. "Nanoliposomes containing three essential oils from the Artemisia genus as effective larvicides against A.aegypti and A.stephensi." Scientific Reports 13 (2023): 11002.

Google Scholar, Crossref, Indexed at